M 1217 Pill - yellow capsule/oblong, 19mm
Pill with imprint M 1217 is Yellow, Capsule/Oblong and has been identified as Levofloxacin 500 mg. It is supplied by Mylan Pharmaceuticals Inc.
Levofloxacin is used in the treatment of Bacterial Infection; Bladder Infection; Anthrax; Anthrax Prophylaxis; Bronchitis and belongs to the drug class quinolones and fluoroquinolones. Risk cannot be ruled out during pregnancy. Levofloxacin 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 1217
Levofloxacin
- Imprint
- M 1217
- Strength
- 500 mg
- Color
- Yellow
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Quinolones and fluoroquinolones
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
croscarmellose sodium,
D&C Yellow No. 10,
FD&C Blue No. 2,
FD&C Yellow No. 6,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polydextrose,
povidone,
corn starch,
sodium lauryl sulfate,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-1217 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0035 (Discontinued) | UDL Laboratories Inc. |
More about levofloxacin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (742)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: quinolones and fluoroquinolones
- Breastfeeding
Patient resources
Other brands
Professional resources
- Levofloxacin monograph
- Levofloxacin (FDA)
- Levofloxacin Injection Concentrate (FDA)
- Levofloxacin Oral Solution (FDA)
- Levofloxacin Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.